Clinical Trials Directory

Trials / Unknown

UnknownNCT05219851

The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors

The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors.in Real-world Clinical Practice: a Multicenter, Prospective, Open, Non-interventional Study

Status
Unknown
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
Hubei Cancer Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this non-interventional study is to collect data on the risk factors for acute radiation pneumonitis in patients with prior receipt of immune checkpoint inhibitors.

Detailed description

1. Incidence of acute radiation pneumonitis (aRPs) in in patients with prior receipt of immune checkpoint inhibitors. 2. Risk factors (especially analysis of the dosimetric risk factor) which may affect the product of aRPs events. 3. Establish a model to predict aRPs and guide clinical treatment.

Conditions

Interventions

TypeNameDescription
RADIATIONCancer patients underwent thoracic intensity-modulated radiotherapyCancer patients underwent thoracic intensity-modulated radiotherapy, previously received ICIs

Timeline

Start date
2022-06-01
Primary completion
2025-03-31
Completion
2025-10-31
First posted
2022-02-02
Last updated
2024-03-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05219851. Inclusion in this directory is not an endorsement.